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a  b  s  t  r  a  c  t
Severe fever with thrombocytopenia syndrome (SFTS) associated with severe fever with
thrombocytopenia  syndrome virus (SFTSV) is an emerging infectious disease. 12 patients
with  severe fever with thrombocytopenia syndrome in our study were presented mainly with
fever and severe malaise. The clinical manifestations typically became worse on the 6th or
7th day. The average fever time is 9.11 ± 1.54 days. Most of them had multiorgan dysfunction,
and  part of them had hemophagocytic lymphohistiocytosis histiocytosis (HLH). The char-
acteristic  laboratory ﬁndings in the early stage were the drop of white blood cells (WBC),
platelets  (PLT) and serum Ca++, while increase of aspartate amino transferase (AST), crea-
tine kinase (CK), and lactate dehydrogenase (LDH). CD3+CD4+ were signiﬁcantly decreased,
while  CD3-CD56+ were signiﬁcantly increased, whereas CD3+CD8+ were constantly elevated
throughout  the disease course. Ten to 14 days after illness onset, symptoms were improved,
accompanied  by resolution of laboratory abnormalities. These results indicate that severe
fever  with thrombocytopenia syndrome has an acute onset and self-limited course. It is
a  systemic infection. The host immune response caused tissues and organs injury. Theimprovement of symptoms and laboratory tests is consistent with the elimination of the
virus  and recover of immune response. Further investigation should be done in order to
better  understand this disease and guide the clinical treatment.
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDAccumulating clinical cases with fever, thrombocytopenia
and multiorgan dysfunction have been reported in Jiangsu
Province  of China since middle 1990s.1,2 In 2010, newly emerg-
ing  patients with the same symptoms in Hubei, Henan
3,4provinces and several other provinces were reported, and
then  a new virus named severe fever with thrombocytopenia
syndrome bunyavirus (SFTSV) was  conﬁrmed5 by sequencing
the  whole genome of the virus. Viruses of the Bunyaviri-
dae family are classiﬁed into ﬁve genera: Orthobunyavirus,
∗ Corresponding author at: Department of Infectious Diseases, The Fi
Medical University, 300 Guangzhou Road, Nanjing 210029, Jiangsu, Chin
E-mail addresses: wengyali@njmu.edu.cn, yaliweng@hotmail.com (
1413-8670©  2013 Elsevier Editora Ltda. 
http://dx.doi.org/10.1016/j.bjid.2013.05.011
Este é um artigo Open Access sob a licençaHantavirus, Phlebovirus, Nairovirus, and Tospovirus. The ﬁrst
four genera can infect mammalian hosts. Most bunyaviruses
are  transmitted by arthropod vectors such as sandﬂies,
mosquitoes, and ticks, whereas the Hantaviruses are main-
tained  in the natural environment as persistent infections of
rodents.6 These viruses can cause hemorrhagic fevers suchrst Afﬁliated Hospital with Nanjing Medical University, Nanjing
a.
Y. Weng).
as  Rift Valley fever (RVF), Crimean-Congo hemorrhagic fever
(CCHF),  hemorrhagic fever with renal syndrome (HFRS), and
Sicilian  sandﬂy fever (SFS) in human beings. They may  also
 de CC BY-NC-ND
 s . 2 0 1 4;1  8(1):88–91  89
c
H
t
m
T
l
E
R
l
r
d
1
(
e
m
i
e
p
p
w
c
t
t
w
4
e
r
e
b
b
t
d
e
f
n
t
p
o
(
n
n
m
s
n
f
t
s
s
a
s
d
i
T
c
9
w
a
10
8
6
4
2
0
250
200
150
100
50
0
1-7D 8-10D
WBC
Lymphocyte
 P<0.01
P<0.05
11-13D
5
P
p
A
B
4
3
2
1
0
Days after symptom onset
Days after symptom onset
W
BC
(*1
0^
9/L
)
PL
T(
*1
0^
9/L
)
Lym(*10^9/L)
≥14D
1-7D 8-10D 11-13D ≥14D
Fig. 1 – Change of WBC, Lymphocytes, and PLT. Changes of
WBC and Lymphocyte are shown in A. Changes of PLT areb r a z j i n f e c t d i
ause encephalitis and acute respiratory diseases.7 Currently,
FRS  and CCHF are endemic in China, and HFRS is an impor-
ant  infectious disease in Jiangsu province.8
Twelve SFTS patients who were admitted to our depart-
ent  from May  to August 2011 were  enrolled in this analysis.
he  disease was  conﬁrmed according to the Clinical Guide-
ines  on Severe Fever with Thrombocytopenia Syndrome (2010
dition)9 released by the Ministry of Health of the People’s
epublic of China. All the data including the clinical data,
aboratory ﬁndings, imaging results, and outcomes were  ret-
ospectively  collected by infectious disease physicians. The
isease  course was  divided into four phases: phase1 (days
–7),  phase2 (days 8–10), phase3 (days 11–13), and phase4
after the 14th day). The changes in serum creatinine, kinases,
lectrolytes and peripheral blood lymphocyte subsets were
onitored  and analyzed. All laboratory tests were performed
n  the First Afﬁliated Hospital of Nanjing Medical University,
xcept for the real-time PCR to conﬁrm SFTSV RNA from
atients  in acute stage (within 14 days since onset) that was
erformed  in Jiangsu CDC.
The statistical analysis was  performed using SPSS soft-
are  17.0 for Windows. Means for continuous variables were
ompared  using independent-group Student’s t tests when
he  data were  normally distributed after Kolmogorov–Smirnov
est; otherwise, the rank sum test was  used. A p-value of <0.05
as  considered statistically signiﬁcant.
These 12 patients (8 men  and 4 women) were  aged between
3  and 79 years (mean: 64.0 years). Ten patients were farm-
rs  living in hilly regions, one was  a forest ranger, and the
emaining  one was  a driver who  went ﬁshing in an open-water
nvironment four days before disease onset. Five patients
elieved that they had ever been bitten by ticks. One had dia-
etes  mellitus and one had undergone prostate resection. All
hese patients were  admitted to the hospital at the 3rd to 7th
ay  from onset of illness (median: at the 6th day). The dis-
ase  onset was  acute in all patients. Whole body sore, extreme
atigue,  and fever (temperatures of 38 ◦C or higher) were also
oted.  The clinical manifestations typically became worse on
he 6th or 7th day when the temperature reached 40 ◦C. When
atients  were  transferred to our hospital 6–7 days after disease
nset,  they complained of extreme fatigue (100.0%), dizziness
83.3%)  and chest distress (50.0%). Most of them felt abdomi-
al  pain (91.7%), diarrhea (91.7%), muscular soreness (75.0%),
ausea  and vomiting (66.7%). Erosion in the oral cavity (41.7%),
ental  sluggishness (25%), petechiae and ecchymosis in the
kin  (33.3%), abdominal tenderness, and superﬁcial lymph
odes  (25%) at the same side of the tick-bitted site were  also
ound.  Ecchymosis in the skin, and melena and bleeding in
he  cavity (41.7%) were  also observed in patients with severe
ymptoms.  They also presented with wet  rales, wheezing
ound, hypoxemia, and some nervous system symptoms such
s dysphoria, hyperalgia, disturbance of consciousness, hyper-
pasmia,  and status epilepticus. Three patients ultimately
ied  of viral meningoencephalitis, hypoxemia, disseminated
ntravascular coagulation (DIC), and multiple organ failure.
hree  of the nine surviving patients persisted with viremia
onstantly. Viral RNA of one patient was  undetectable at day and two at day 10. The body temperature returned normal
hen  virus RNA detection turned out negative, with a temper-
ture  recovery time of 9.11 ± 1.54 days.shown  in B.
At the ﬁrst week after disease onset, white blood cell (WBC),
lymphocyte and platelet (PLT) counts dropped to the valley
levels.  Then, at day 8–10, WBC  and lymphocyte started to
increase,  while PLT rose up slowly until day 11–13. The WBC
and  lymphocyte counts at phase1 were signiﬁcantly lower
than  at phases 2, 3, and 4 (p < 0.01), while the PLT count at
phase  1 was signiﬁcantly lower than at phases 3 and 4 (p < 0.01)
and  the PLT count at phase 2 was  signiﬁcantly lower than at
phase  4 (p < 0.01). There was  no difference of WBC  and lym-
phocyte  counts, but a statistical difference of PLT count was
found  between phase 2 and phase 3, as well as between phase
3  and phase 4 in pair-wise comparison (p < 0.05) (Fig. 1). Urine
protein  and, microscopically, red blood cells were  detected in
all 12 patients at the early stage. The average time of urine
normalization was 14.11 ± 2.20 days. The LDH, CK, and AST
levels  remarkably increased at the early stage, and CK and AST
remained  so for 10 days while LDH returned to normal after 13
days  (Fig. 2), in contrast to the ALT level that elevated slightly.
BUN  and Cr remained normal. Serum Ca++ was  reduced until
day  13. Compared to those in the mid- to late-stage (day 8–13),
90  b r a z j i n f e c t d i s . 2
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Fig. 2 – Change of serum AST, LDH, and CK. LDH, CK and
AST  levels was  increased clearly at the early stage. There is
no  difference of increasing of LDH, CK and AST levels
between phase 1 and phase 2 (p > 0.05); but a statistical
difference of these changes was  found at phase 1, phase 3
(p < 0.05) and phase 4 (p < 0.01) in pair wise comparison.
The  statistical difference was  also found at phase 2, phase
3  (p < 0.05) and phase 4 (p < 0.01) in pair wise comparison.
However,  statistical difference of the change of LDH
(p  < 0.05) was  found only at phase 3 and phase 4 in pair
wise comparison.
CD3+ and CD3+CD4+ were signiﬁcantly decreased in phase
1  and resumed to increase from phase 3, while CD3-CD56+
were  signiﬁcantly increased in phase1 and started to decrease
from  phase 3. CD3+CD8+ was  constantly elevated in every
stage,  and there was  no statistical difference (Fig. 3). Nine
patients  received bone marrow examination. Histocytes and
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Fig. 3 – Flow cytometric analysis of peripheral blood
lymphocyte subset counts of patients. CD3+ and CD4+ were
signiﬁcantly  decreased in phase 1 and started to increase
from  phase 3, while CD3-CD56+ was  signiﬁcantly increased
in  phase1 and started to decrease from phase 3. There is a
statistical  difference at phase 1 and phase 3 (p < 0.05),
phase1 and phase 4 (p < 0.01) of CD3-CD56+. A statistical
difference was  found at phase 1 and phase 3, phase 1 and
phase  4, phase 2 and phase 4 (p < 0.05) in pair wise
comparison of CD3+ and CD4+. CD3+CD8+ were  at high
level  in every stage, but there was  no difference in pair
wise  comparison (p > 0.05). 0 1 4;1  8(1):88–91
phagocytes were  occasionally found in one patient and clearly
seen  in seven patients. The proportion of histocytes or
phagocytes ranged 2–11.2%. All patients had active myeloid
hyperplasia. Obvious vacuolar degeneration in neutrophils
was  observed in two patients and inclusion bodies in some
neutrophils were found in one patient. The proportion of lym-
phocytes  was low in seven patients, and shaped lymphocytes
were  observed. Bone marrow culture for bacteria turned out
negative.
Patients  were treated mainly with symptomatic treatment,
supporting therapy such as plasma, platelet, granulocyte
colony stimulating factor (GCSF), recombinant human inter-
leukin  11, and gamma  globulin. Meanwhile, measures were
taken  to maintain water and electrolyte balance and to
treat  complications. Nine SFTS patients (75%) included three
patients  with hemophagocytic lymphohistiocytosis histiocy-
tosis  (HLH) who recovered, while three (25%) patients (aged
58,  70, and 74 years, respectively) ultimately died of viral
meningoencephalitis, status epilepticus, coma, hyoxemia and
encephaledema  at day 8, 9, and 10 day in the course of illness,
respectively. Among them, two had HLH.
We herein analyzed 12 patients with SFTSV infection. Most
of  them lived in hilly areas, and ﬁve were bitten by ticks.
It  seemed that tick bite was  the main route of transmission
of  this disease. Older patients tended to have more  severe
symptoms perhaps due to their lower immunological capac-
ity  to limit the replication of SFTSV. In our series, the disease
onset  was  acute in all the 12 patients, along with diverse
clinical manifestations. Most patients developed multiorgan
dysfunction, whereas hyperspasmia and obnubilation were
seen  in critically ill patients. Elevated serum levels of AST,
CK,  and LDH, as well as urinary protein and red blood cells in
the  early stage of the disease indicated dysfunction in these
organs.  One of the characteristic laboratory ﬁndings in the
early  stage was  WBC  and PLT drop. The major cause of throm-
bocytopenia may  be the enhanced clearance of virus-bound
platelets promoted by splenic macrophages.10 Also in our
cases,  we found that histocyte and phagocyte were  present in
the bone marrow of most patients. According to the diagnostic
criteria  for hemophagocytic lymphohistiocytosis histiocyto-
sis  (HLH) issued by the American Society of Hematology in
2009,11 ﬁve cases could be conﬁrmed as HLH. HLH is a disease
characterized by excessive inﬂammatory response. Although
hemorrhagic fever with renal syndrome (HFRS) is a common
disease  in China, it has been rarely reported that it can lead
to  HLH. More  importantly, considering the high percentage
and  severity of HLH cases caused by Bunyavirus, it is impor-
tant  to further explore its pathogenesis, clinical treatment
and  clinical outcome. We  found that at the early stage, the
amount  of NK cells increased dramatically, and then gradu-
ally  returned to normal after two weeks, while the amount of
CD8+T  cells increased constantly and did not return to normal
in  two weeks. It is necessary to do further research to clarify
the  function of NK cells and CD8+T cells in SFTV infection.12,13
By tracking three patients with viremia, we  found that the
recovery  time of body temperature, as well as other symp-
toms  and laboratory data, are consistent with the presence
of  viremia.14 This phenomenon was  often observed in other
six  surviving patients. We also observed that the dynamic
changes of WBC, lymphocytes, PLT, serum Ca++, LDH, CK, and
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http://dx.doi.org/10.1371/journal.pone.0041365.
16. Sun Y, Jin C, Zhan F, et al. Host cytokine storm is associatedb r a z j i n f e c t d i
ST were  consistent with the viral replication and the num-
er  of Th cells, Tc cells and NK cells, suggesting that viral
eplication and host immune responses play an important
ole  in determining the clinical outcome. Because of the lim-
ted  number of cases, further studies with larger number of
ases  are warranted to investigate the relationship between
iremia,  host immune status and clinical outcomes. Our study
rovided  detailed clinical analyses of patients infected with
FTSV,  as well as laboratory data and immunologic parameters
ver  time. Most SFTS cases experienced an acute, self-limiting
isease  course and recovered within two weeks if the patients
ad  relatively mild symptoms and no complications. How-
ver,  a few patients suffered from severe bleeding and central
ervous  system symptoms and died due to multiorgan dys-
unction.  Cytokine storm might be in part responsible for the
isease  progression.15,16 As an emerging infectious disease,
linical types, pathophysiology, pathogenesis, and treatment
f  SFTS need to be further addressed in future studies.
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